Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dattatraya Patil

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Clinical Genitourinary Cancer|February 1, 2020
Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC)Hiroshi Fukushima, Kazutaka Saito, Yosuke Yasuda, et al.
Urologia Internationalis|February 28, 2015
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved PrognosisSarah A Holzman, Claire M de la Calle, Haydn T Kissick, et al.
Asian Journal of Urology|April 8, 2020
A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomyAnne Holck Storås, Martin G Sanda, Olatz Garin, et al.
Urology|April 16, 2020
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell CarcinomaDattatraya Patil, Thien-Linh Le, Kc Biebighauser Bens, et al.
The Canadian Journal of Urology|July 8, 2026
Understanding the utilization of genetic counseling and testing among patients with prostate cancerErnest A Morton, Reza Lahiji, Elizabeth Chu, et al.
Clinical Genitourinary Cancer|April 12, 2022
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) CohortMasahiro Toide, Kazutaka Saito, Yosuke Yasuda, et al.
The Journal of Urology|April 30, 2020
[<sup>18</sup>F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate CancerMehrdad Alemozaffar, Akinyemi A Akintayo, Olayinka A Abiodun-Ojo, et al.
Urologic Oncology|January 17, 2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technologyRobert Steven Gerhard, Dattatraya Patil, Yuan Liu, et al.
The Prostate|April 19, 2017
Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urineKathryn L Pellegrini, Dattatraya Patil, Kristen J S Douglas, et al.
Clinical Genitourinary Cancer|January 19, 2016
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish PatientsAnne Holck Storås, Martin G Sanda, Olatz Garin Boronat, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Clinical Genitourinary Cancer|February 1, 2020
Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC)Hiroshi Fukushima, Kazutaka Saito, Yosuke Yasuda, et al.
Urologia Internationalis|February 28, 2015
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved PrognosisSarah A Holzman, Claire M de la Calle, Haydn T Kissick, et al.
Asian Journal of Urology|April 8, 2020
A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomyAnne Holck Storås, Martin G Sanda, Olatz Garin, et al.
Urology|April 16, 2020
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell CarcinomaDattatraya Patil, Thien-Linh Le, Kc Biebighauser Bens, et al.
The Canadian Journal of Urology|July 8, 2026
Understanding the utilization of genetic counseling and testing among patients with prostate cancerErnest A Morton, Reza Lahiji, Elizabeth Chu, et al.
Clinical Genitourinary Cancer|April 12, 2022
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) CohortMasahiro Toide, Kazutaka Saito, Yosuke Yasuda, et al.
The Journal of Urology|April 30, 2020
[<sup>18</sup>F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate CancerMehrdad Alemozaffar, Akinyemi A Akintayo, Olayinka A Abiodun-Ojo, et al.
Urologic Oncology|January 17, 2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technologyRobert Steven Gerhard, Dattatraya Patil, Yuan Liu, et al.
The Prostate|April 19, 2017
Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urineKathryn L Pellegrini, Dattatraya Patil, Kristen J S Douglas, et al.
Clinical Genitourinary Cancer|January 19, 2016
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish PatientsAnne Holck Storås, Martin G Sanda, Olatz Garin Boronat, et al.
Pageof 15